Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Jan 2026, Feb 2026, Mar 2026 and Oct 2026.
- Largest single sale: $3.6M (60,000 shares) of CRISPR Therapeutics AG on Jan 22, 2026. Filing
- Last sale before this period: Oct 14, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | Chief Executive Officer, Director | Oct 18, 2016 | Oct 15, 2026 |
| Oruka Therapeutics, Inc. (ORKA) | Director | Sep 6, 2024 | Jun 3, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 14, 2026, CRISPR Therapeutics AG: sold 4,098 shares for $202K, to cover taxes. 1 filing: 1
- Oct 13, 2026, CRISPR Therapeutics AG: 8,333 shares vested. 1 filing: 1
- Mar 23, 2026, CRISPR Therapeutics AG: sold 10,020 shares for $469K, to cover taxes. 1 filing: 1
- Mar 20, 2026, CRISPR Therapeutics AG: 19,687 shares vested. 1 filing: 1
- Mar 16, 2026, CRISPR Therapeutics AG: sold 10,349 shares for $499K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.